ZURA Q1 2026 Earnings PreRevenue Biotech Reports WiderThanExpected Loss Phreesia PHR Q1 2026 Earnings EPS Misses Estimates But Stock Gains on Positive Earnings Beat RSG Q1 2026 Earnings EPS Beat Driven by Operational Efficiency Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Per Share Exceeds Expectations Despite Stock Decline iBio Inc IBIO Q1 2026 Earnings EPS Miss on Higher RD Spend Stock Rises Despite No Revenue UFCS Q1 2026 Earnings Strong EPS Beat Driven by Underwriting Discipline